Active

SNEL-PRESS

Switched

BE0445079253

Rechtspersoon Private limited company 1 establishment

Turfstraat 3, 3581 Beringen

Active for

34 year, 11 months

Financials

Financial year 2022

Worth noting

  • A loss two years in a row.

Gross margin

€ -6,859

▼ 140% vs 2021

Profit

Caution

€ -5,729

▲ 81% vs 2021

Debts

Low

€ 32,491

▼ 22% vs 2021

SNEL-PRESS from Beringen, company number BE0445079253, closed financial year 2022 with a result of € -5,729 after tax. For that financial year SNEL-PRESS recorded a gross margin of € -6,859 and equity of € 53,088. Compared with financial year 2021, the result moved from € -29,759 to € -5,729. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2023.

What happened at SNEL-PRESS?

What happened at SNEL-PRESS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2022: loss of € 5,729. filed late Source: NBB ↗
  • NURCAN GULFIDAN became a director. NBB
  • New establishment in Tienen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 29,759 loss in 2021 to € 5,729 loss in 2022.

A new publication or filing at SNEL-PRESS? We notify you, reason included.

Follow SNEL-PRESS

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

NURCAN GULFIDAN
SNEL-PRESS

Behind SNEL-PRESS is NURCAN GULFIDAN. NURCAN GULFIDAN is also behind Limlodec.

See the full network in the app

Directors

According to the 2022 annual accounts

NURCAN GULFIDAN

Director

Also active at: Limlodec

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Turfstraat 3

3581 Beringen

2.054.438.719

Nieuwstraat 7

3300 Tienen

Active since 7 October 1991

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0445.079.253
VAT number
BE 0445.079.253
Registered office
Turfstraat 3, 3581 Beringen
Names & denominations
SNEL-PRESS
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Opening faillissement
Start date
10 September 1991
Peppol
Not registered

Frequently asked questions

What is the enterprise number of SNEL-PRESS?
The enterprise number of SNEL-PRESS is BE0445079253.
What is the address of SNEL-PRESS?
The registered office of SNEL-PRESS is located at Turfstraat 3, 3581 Beringen.
When was SNEL-PRESS founded?
SNEL-PRESS was founded on 10 September 1991.
Does SNEL-PRESS have a website?
No website is currently known for SNEL-PRESS.
How much profit did SNEL-PRESS make in 2022?
SNEL-PRESS recorded a loss after taxes of € 5,729 in financial year 2022.
What is the revenue of SNEL-PRESS?
As a small company, SNEL-PRESS is not required to publish revenue in its annual accounts. In financial year 2022, its added value was € -6,859.
Where can I find the annual accounts of SNEL-PRESS?
SNEL-PRESS files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of SNEL-PRESS?
According to the 2022 annual accounts, the directors of SNEL-PRESS are: NURCAN GULFIDAN.
Who owns SNEL-PRESS?
Behind SNEL-PRESS is NURCAN GULFIDAN. NURCAN GULFIDAN is also behind Limlodec.